{
    "2019-03-15": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Roche Gets Approval for Label Expansion of MabThera in Europe",
                "features": {
                    "keywords": [
                        "Roche",
                        "Approval",
                        "Label Expansion",
                        "MabThera",
                        "Europe"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamis Opioid Overdose Drug NDA",
                "features": {
                    "keywords": [
                        "KaryoPharm",
                        "Selinexor",
                        "Review Delayed",
                        "FDA",
                        "Adamis",
                        "Opioid Overdose",
                        "Drug NDA"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}